Canada· CA-DIN-02224623
SOFRACORT
A dexamethason und antiinfektiva product containing dexamethasone (dexamethasone sodium metasulphobenzoate) + framycetin sulfate + gramicidin, registered in Canada by CHEPLAPHARM ARZNEIMITTEL GMBH. The same ATC class is registered in 2 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Dexamethason und antiinfektiva is registered in 2 of 19 countries.
Countries holding a registration under ATC S03CA01 (dexamethason und antiinfektiva), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Dexamethason und antiinfektiva · ATC S03CA01
2 / 19 countries
- Canada
- Finlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DEXAMETHASONE (DEXAMETHASONE SODIUM METASULPHOBENZOATE) + FRAMYCETIN SULFATE + GRAMICIDIN
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Country
- Canada (CA)
- ATC code
- S03CA01
- ATC class
- Dexamethason und Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason und antiinfektiva in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Netherlands · Sofradex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40615a1e-c9f5-4f3f-9072-0f2aaa8e2218 GET /v1/drugs/40615a1e-c9f5-4f3f-9072-0f2aaa8e2218?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02224623",
"form": "DROPS",
"class": "Human",
"routes": [
"OTIC",
"OPHTHALMIC"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "S03CA01",
"schedule": [
"Prescription"
],
"drug_code": "37363",
"strengths": [
"0.5 MG",
"5 MG",
"0.05 MG"
],
"ahfs_class": null,
"substances": [
"DEXAMETHASONE (DEXAMETHASONE SODIUM METASULPHOBENZOATE)",
"FRAMYCETIN SULFATE",
"GRAMICIDIN"
],
"product_categorization": null
}See everything about dexamethason und antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.